Share Capital (Tables)
|
12 Months Ended |
Dec. 31, 2018 |
|---|
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
|
| Summary of stock option activities and related information |
| |
|
Number of ordinary shares |
|
|
Number of ordinary shares |
|
| |
|
Authorized |
|
|
Issued and outstanding |
|
|
Authorized |
|
|
Issued and outstanding |
|
| |
|
December 31, 2018 |
|
|
December 31, 2017 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares |
|
|
200,000,000 |
|
|
|
23,491,948 |
|
|
|
100,000,000 |
|
|
|
21,737,263 |
|
|
| Summary of options granted outstanding and exercise prices |
| |
|
Number of options |
|
|
Weighted average exercise price |
|
|
Weighted average remaining contractual
life
(years)
|
|
|
Aggregate intrinsic-value |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding as of January 1, 2018 |
|
|
1,429,713 |
|
|
$ |
0.63 |
|
|
|
|
|
|
|
|
|
| Granted |
|
|
706,365 |
|
|
|
0.36 |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
(64,631 |
) |
|
|
0.02 |
|
|
|
|
|
|
|
|
|
| Options forfeited |
|
|
(357,408 |
) |
|
$ |
1.01 |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding as of December 31, 2018 |
|
|
1,714,039 |
|
|
$ |
0.63 |
|
|
|
6.08 |
|
|
$ |
25,519 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable as of December 31, 2018 |
|
|
793,486 |
|
|
$ |
0.75 |
|
|
|
4.85 |
|
|
$ |
25,519 |
|
| |
|
Outstanding |
|
|
Exercisable |
|
| Exercise price |
|
Number of options |
|
|
Weighted average remaining contractual life (years) |
|
|
Number of options |
|
|
Weighted average remaining contractual life (years) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| (*) |
|
|
230,425 |
|
|
|
4.4 |
|
|
|
230,425 |
|
|
4.4 |
|
|
| $0.03 |
|
|
22,565 |
|
|
|
8.7 |
|
|
|
22,565 |
|
|
8.7 |
|
|
| 0.27 |
|
|
611,500 |
|
|
|
6.8 |
|
|
|
53,600 |
|
|
6.9 |
|
|
| 0.34 |
|
|
8,020 |
|
|
|
5.1 |
|
|
|
8,020 |
|
|
5.1 |
|
|
| 0.45 |
|
|
63,097 |
|
|
|
1.7 |
|
|
|
63,097 |
|
|
1.7 |
|
|
| 0.92 |
|
|
743,753 |
|
|
|
6.4 |
|
|
|
381,100 |
|
|
6.3 |
|
|
| 4.72 |
|
|
1,068 |
|
|
|
3.2 |
|
|
|
1,068 |
|
|
3.2 |
|
|
| 5.05 |
|
|
2,769 |
|
|
|
3.2 |
|
|
|
2,769 |
|
|
3.2 |
|
|
| 5.73 |
|
|
29,981 |
|
|
|
3.3 |
|
|
|
29,981 |
|
|
3.3 |
|
|
| $6.23 |
|
|
861 |
|
|
|
6.5 |
|
|
|
861 |
|
|
6.5 |
|
|
| |
|
|
1,714,039 |
|
|
|
|
|
|
|
793,486 |
|
|
|
|
|
| |
(*) |
Represents an amount
lower than $0.01. |
|
| Summary of stock based compensation |
| |
|
Year Ended December 31, |
|
| |
|
2018 |
|
|
2017 |
|
|
2016 |
|
| |
|
|
|
|
|
|
|
|
|
| Cost of revenues |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(99 |
) |
| Research and Development |
|
|
36,723 |
|
|
|
17,956 |
|
|
|
8,828 |
|
| Sales and Marketing |
|
|
14,837 |
|
|
|
9,747 |
|
|
|
7,220 |
|
| General and Administrative |
|
|
102,430 |
|
|
|
108,431 |
|
|
|
36,440 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
$ |
153,990 |
|
|
$ |
136,134 |
|
|
$ |
52,389 |
|
|
| Summary of outstanding warrants |
| Outstanding |
|
|
Issuance year |
|
Exercise price |
|
|
Exercisable through |
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
117,209 |
|
|
2009 |
|
$ |
(* |
) |
|
Exit event |
|
Refer to Note 9b |
| |
59,384 |
|
|
2013 |
|
|
0.92 |
|
|
2023 |
|
(***) |
| |
32,964 |
|
|
2014 |
|
|
1.50 |
|
|
(**) |
|
(***) |
| |
170,000 |
|
|
2018 |
|
|
0.50 |
|
|
2023 |
|
Refer to Note 8d |
| |
600,000 |
|
|
2018 |
|
|
0.50 |
|
|
2023 |
|
Refer to Note 8e |
| |
466,667 |
|
|
2018 |
|
$ |
0.50 |
|
|
2023 |
|
Refer to Note 11b7 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
1,446,224 |
|
|
|
|
|
|
|
|
|
|
|
| |
(*) |
Represents an amount
lower than $0.01 |
| |
(**) |
The earlier of:
5 years from the issuance date or the consummation of a PO or Merger and Acquisition (“M&A”) Transaction. |
| |
(***) |
Issued in connection
with 2014 and 2013 arrangements. |
|